April 9 (Reuters) - Hemostemix Inc HEM.V :
* HEMOSTEMIX ANNOUNCES ENROLLMENT MILESTONE IN THE ACP-01 PHASE II CRITICAL LIMB ISCHEMIA CLINICAL TRIAL
* HEMOSTEMIX INC - REACHED AN ENROLLMENT MILESTONE IN ITS CONTINUING PHASE II CLINICAL TRIAL FOR CRITICAL LIMB ISCHEMIA
* HEMOSTEMIX INC - ENROLLMENT RATES HAVE INCREASED SUBSTANTIALLY OVER PAST SEVERAL WEEKS, WITH AN ADDITIONAL 9 PATIENTS ENROLLED